EFFICACY ANALYSIS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 140 PEDIATRIC PATIENTS WITH KMT2A REARRANGEMENTS ACUTE MYELOID LEUKEMIA

EHA Library, Rui-juan sun, 4161113

ROLE OF PRE-TRANSPLANT PCR ON CLINICAL OUTCOME IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Yu-sin Wu, 4161114

GERIATRIC ASSESSMENT SCORE FOR PREDICTING DISEASE RELAPSE IN OLDER ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS: RESULTS FROM A PROSPECTIVE ITALIAN SINGLE-CENTER STUDY.

EHA Library, Eugenia Accorsi Buttini, 4161115

ITALIAN RETROSPECTIVE REAL-LIFE ANALYSIS ON BELUMOSUDIL FOR TREATMENT-RESISTANT/REFRACTORY CHRONIC GVHD

EHA Library, Francesca Bonifazi, 4161116

THE STUDY ON THE CORRELATION BETWEEN DONOR CHEMOKINE RECEPTOR GENE POLYMORPHISM AND ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Tao Wu, 4161117

MEASURABLE CYCLOPHOSPHAMIDE ON DAY 0 OF ALLOGENEIC STEM CELL TRANSPLANTATION ADVERSELY IMPACTS GRAFT-VERSUS-HOST DISEASE AND SURVIVAL OUTCOMES

EHA Library, Ray Mun Koo, 4161119

SAFETY AND EFFICACY OF GCSF ALONE WITH PRE-EMPTIVE PLERIXAFOR FOR AUTOLOGOUS PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL MOBILIZATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Mohamed Elemary, 4161120

HYPOMETHYLATING AGENTS AND VENETOCLAX FOR RELAPSE PREVENTION IN PATIENTS WITH HIGH-RISK MYELOID MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Liping Wan, 4161121

THE HAPLOID HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH UMBILICAL CORD BLOOD TRANSFUSION IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES: A MULTICENTER, SINGLE-ARM PROSPECTIVE TRIAL

EHA Library, Xianbo Huang, 4161122

INVASIVE FUNGAL DISEASE IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH ANTIFUNGAL PROPHYLAXIS

EHA Library, cao jiaxin, 4161123

DYNAMIC IMMUNE RECONSTITUTION IN MIXED CHIMERISM: MECHANISMS LINKING TO GRAFT STABILITY AND CLINICAL OUTCOMES IN SEVERE APLASTIC ANEMIA AFTER HLA-MATCHED TRANSPLANTATION

EHA Library, Ming-Hao Lin, 4161124

ASSESSMENT OF CIRCULATING CELL FREE DNA AND CYTOKINE LEVELS IN HEMATOPOIETIC STEM CELL DONORS

EHA Library, Tatyana Rybolovleva, 4161126

OUTCOMES BETWEEN SECONDARY AND DE NOVO ACUTE MYELOID LEUKEMIA IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING IN FIRST COMPLETE REMISSION: A PROPENSITY SCORE-MATCHED STUDY.

EHA Library, Nan Yang, 4161127

A NOVEL CONDITIONING REGIMEN COMBINING SELINEXOR WITH MELPHALAN IMPROVES SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA:A PROSPECTIVE STUDY

EHA Library, Liangliang Ma, 4161128

COMPARISON OF THE 25 VS 50 MG/KG POST-TRANSPLANTATION CYCLOPHOSPHAMIDE DOSES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Turgay Ulas, 4161130

REDUCED TOXICITY CONDITIONGING REGIMEN CONTAINING DECITABINE IS FEASIBLE AND ACHIEVES COMPARABLE CLINICAL OUTCOME IN ELDERLY AND FRAGILE MDS PATIETNS RECEIVED STEM CELL TRANSPLATATION: A RETROSPECTIVE, SINGLE-CENTER ANALYSIS

EHA Library, yanling Ren, 4161131

AMBULATORY DELIVERY OF AUTOLOGOUS STEM CELL TRANSPLANT WITH BEAM CONDITIONING IS SAFE AND RESULTS IN REDUCED INPATIENT STAYS

EHA Library, Pierre McCarthy, 4161132

LONG-TERM FOLLOW-UP AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Baazizi Mounira, 4161133

CLINICAL EFFECTS OF RUNX1 MUTATIONS ON THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION

EHA Library, WeiJie Ran, 4161134

A NEW RISK FACTOR FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN PEDIATRIC RECIPIENTS: LOWER CD4 T CELL COUNTS AROUND 30 DAYS AFTER HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Yangyang Gao, 4161135

CHARACTERISTICS AND OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ERCC6L2-ASSOCIATED BONE MARROW FAILURE AND MYELOID MALIGNANCIES: SINGLE-CENTER REPORT OF 9 CASES

EHA Library, Alfadil Haroon, 4161136

SURVIVAL BENEFIT OF ALLOGENEIC HSCT IN CMML PATIENTS DURING THE MOLECULAR STRATIFICATION ERA: A MULTICENTER COHORT STUDY

EHA Library, Rui Ma, 4161137

CONVALESCENT PLASMA THERAPY FOR COVID-19 PROPHYLAXIS IN ADULTS EARLY POST-HEMATOPOIETIC STEM CELL TRANSPLANTATION: ONE-YEAR OUTCOMES FROM A RANDOMIZED CONTROLLED TRIAL

EHA Library, Yigeng Cao, 4161138

PREDICTORS OF OUTCOMES IN ACUTE MYELOID LEUKEMIA WITH KMT2A REARRANGEMENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Betul Oran, 4161139

DYNAMIC OUTCOME PREDICTION BY NT-PROBNP KINETICS FOLLOWING POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS

EHA Library, Niek van der Maas, 4161140

ANALYSIS OF THE DIAGNOSTIC VALUE OF METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS) FOR INFECTIONS FOLLOWING THE HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yang Yan, 4161141

EFFICACY AND SAFETY OF RUXOLITINIB COMBINED WITH STEROIDS FOR FIRST-LINE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SINGLE-CENTER, REAL-WORLD EXPERIENCE

EHA Library, Yang Yan, 4161142

LONG TERM OUTCOME OF αßTCR/CD19 DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA. A SINGLE CENTER EXPERIENCE.

EHA Library, Lucia Prezioso, 4161143

ESTABLISHING A NOVEL GI-GVHD PREDICTION MODEL BASED ON MAIT CELLS AND DONOR-RECIPIENT CLINICAL CHARACTERISTICS

EHA Library, Mengge Gao, 4161144

DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR SEVERE PRE-ENGRAFTMENT SYNDROME DURING THE TREATMENT OF UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC PATIENTS

EHA Library, shiyuan wang, 4161145

EXPOSURE RESPONSE OF RAVULIZUMAB TO TREAT PEDIATRIC PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Jonathan Monteleone, 4161146

ANALYSIS OF BASELINE AND CLINICAL CHARACTERISTICS OF EUROPEAN AND ITALIAN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE: INSIGHTS INTO CURRENT TREATMENT LANDSCAPE IN ITALY

EHA Library, Francesca Bonifazi, 4161147

REAL WORLD TREATMENT DURATION IN PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE RECEIVING BELUMOSUDIL COMPARED TO BEST AVAILABLE THERAPY (ROCKREAL)

EHA Library, Kevin Hall, 4161148

SPLENOMEGALY AND LOW CD34+ CELL DOSE ARE ASSOCIATED WITH POOR GRAFT FUNCTION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MYELOFIBROSIS

EHA Library, Portia Smallbone, 4161149

SIROLIMUS-STEROID COMBINATION VS. STEROID MONOTHERAPY AS FIRST-LINE TREATMENT FOR CHRONIC GVHD: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Xi Zhang, 4161150

USING PSM COMPARING THE PROGNOSTIC DIFFERENCES BETWEEN FIRST-LINE AUTOLOGOUS TRANSPLANTATION AND CHEMOTHEROPY ALONE IN NEWLY DIAGNOSED DLBCL PATIENTS WITH IPI ≥3

EHA Library, Hongmei Jing, 4161151

BREAKING AGE BARRIERS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: EXPLORING THE SAFETY AND EFFICACY OF POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED PROPHYLAXIS IN ADULTS ACCORDING TO AGE RANGES

EHA Library, Gorka Pinedo Martín, 4161152

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING DECEASED DONOR DERIVED CRYOPRESERVED BONE MARROW: A FIRST-IN-HUMAN REPORT OF SUCCESSFUL ENGRAFTMENT IN PRESERVE 1

EHA Library, Sagar Patel, 4161153

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR DIAMOND-BLACKFAN ANEMIA: FAVORABLE OUTCOMES FROM A SINGLE CENTER

EHA Library, Lan He, 4161154

EXPANSION OF CYTOTOXIC T LYMPHOCYTES POST-ALLOGENEIC TRANSPLANT: FACTORS INVOLVED IN THEIR DEVELOPMENT AND IMPACT ON TRANSPLANT OUTCOMES

EHA Library, Jaime Ortiz Andrade, 4161155

SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA IN THE ERA OF IMMUNOTHERAPY: OUTCOMES AND PROGNOSTIC RISK FACTORS

EHA Library, Rui Wang, 4161156

SINGLE-CENTER RETROSPECTIVE ANALYSIS OF THE PROGNOSIS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MLL-AF6 FUSION GENE POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Xingyu Cao, 4161157

CLINICAL STUDY OF CLADRIBINE-CONTAINING CONDITIONING REGIMEN IN HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Yi Zhu, 4161158

TREOSULFAN-BASED CONDITIONING IN ALLO-HCT FOR OLDER ADULTS: LESS TOXICITY, LOWER ENDOTHELIAL ACTIVATION, AND COMPARABLE OUTCOMES

EHA Library, Maria Queralt Salas, 4161160

SEQUENTIAL ALLOGENEIC STEM CELL TRANSPLANTATION FOR VENETOCLAX-EXPOSED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2

EHA Library, Andrius Žučenka, 4161161

SAFETY AND EFFICACY OF POMALIDOMIDE AND AZACITIDINE COMBINATION IN MRD-GUIDED PREEMPTIVE TREATMENT OF ACUTE LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lu Wang, 4161162

HYPERTENSION IS UNDERDIAGNOSED AND ASSOCIATED WITH THE PRESENCE OF SUBCLINICAL VASCULAR DAMAGE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Wejdan Bin Obaid, 4161163

DUAL EPIGENETIC MODULATION: DECITABINE-AUGMENTED MYELOABLATIVE CONDITIONING WITH POST-HSCT LOW-DOSE HMA MAINTENANCE ACHIEVES 100% SURVIVAL WITH CLONAL ERADICATION IN PEDIATRIC GATA2 DEFICIENCY-ASSOCIATED MYELOID MALIGNANCIES

EHA Library, Yuanyuan Ren, 4161164

HEMATOPOIETIC STEM CELL TRANSPLANT IN INFANTILE OSTEOPETROSIS: NAVIGATING THROUGH THE MAZE

EHA Library, Hashim Khan, 4161165

PARTIAL REPLACEMENT OF POST-TRANSPLANT CYCLOPHOSPHAMIDE WITH BENDAMUSTINE AS GVHD PROPHYLAXIS IN HAPLOIDENTICAL STEM CELL TRANSPLANTS IN PEDIATRIC PATIENTS:EXPERIENCE FROM A TERTIARY CARE CENTER

EHA Library, Ranjith CS, 4161166

THE FIRST ALLOGENEIC STEM CELL TRANSPLANT IN KENYA: A CASE REPORT

EHA Library, Rohini Radia, 4161167

S100A8/A9 SIGNALING CAUSES MITOCHONDRIAL DYSFUNCTION AND MEGAKARYOCYTE APOPTOSIS IN ACUTE MYELOID LEUKEMIA

EHA Library, Mengyu Xiao, 4161168

CAUSES AND CONSEQUENCES OF CLONAL HEMATOPOIESIS WITH UNKNOWN DRIVERS IN 409,553 WHOLE-GENOME SEQUENCED UK BIOBANK PARTICIPANTS

EHA Library, Sean Wen, 4161169

LOSS OF HEPCIDIN IMPAIRS 5-FU-INDUCED HEMATOPOIETIC STEM CELL REGENERATION

EHA Library, Marta Lopes, 4161170

MAINTENANCE OF QUIESCENT HEMATOPOIETIC STEM CELLS ACROSS DEVELOPMENT IN SINGLE GROWTH FACTOR-BASED CULTURE

EHA Library, Margarita MacAldaz, 4161171

PHARMACOLOGICAL ACTIVATION OF CAMP PATHWAY PROTECTS HUMAN HEMATOPOIETIC STEM CELLS FROM CAR-T INDUCED HEMATO-TOXICITY

EHA Library, Siva Sai Naga Anurag Muddineni, 4161172

DEVELOPMENT OF A TRACTABLE EX VIVO MODEL OF HAEMATOPOIESIS

EHA Library, Elizabeth Brown, 4161173

ELEVATED UBE2G1 EXPRESSION IN HSCS LEADS TO PREMATURE AGING OF THE HAEMATOPOIETIC SYSTEM

EHA Library, Julian Niemann, 4161174

DEVELOPMENTAL DIFFERENCES IN HEMATOPOIETIC LINEAGE DIFFERENTIATION REVEALED BY SINGLE CELL ATAC-SEQ OF FIRST TRIMESTER HUMAN FETAL LIVER

EHA Library, Sara Palo, 4161175

EXPRESSION OF KIT D814V IN MURINE HEMATOPOIETIC STEM CELLS RESULTS IN AN ADVANCED SYSTEMIC MASTOCYTOSIS PHENOTYPE WITH ASSOCIATED MYELOID NEOPLASM

EHA Library, Simona Stivala, 4161176

SPECIFIC GENETIC ALTERATIONS IN BCMA POSITIVE CELLS UNCOVER MYELOPROLIFERATIVE PHENOTYPES AND AN IMMUNOSUPPRESSIVE NICHE IN MURINE HEMATOPOIETIC MODELS

EHA Library, Álvaro Otero-Sobrino, 4161177

RAPID RESPONSE OF NEUTROPHILS DETERMINED BY THE SHORTEST LINEAGE COMMITMENT TRAJECTORY AND MINIMAL SIGNALING CHANGES

EHA Library, Yongjian Yue, 4161178

CH-MUTATED MACROPHAGES CONTRIBUTE TO A PERMISSIVE BONE MARROW NICHE FOR MALIGNANT TRANSFORMATION.

EHA Library, Sarah Mackie, 4161179

MACROPHAGE DEPLETION ALTERS MSC FUNCTION AND DIFFERENTIATION UNDER CHRONIC STRESS CONDITIONS

EHA Library, Sanja Momčilović, 4161180

SINGLE-CELL MAPPING OF HUMAN BONE MARROW STROMAL CELLS REVEALS SUBPOPULATION DIVERSITY AND STRESS-INDUCED REMODELING

EHA Library, Charles Bataclan, 4161181

THE GENERATION OF A TRACEABLE DNMT3A AND TET2 KNOCKOUT IN HUMAN HSCS ENABLES IN VITRO AND IN VIVO MODELING OF CLONAL HEMATOPOIESIS.

EHA Library, Bauke de Boer, 4161182

CELL DIVISION IS ABSENT DURING LINEAGE COMMITMENT OF HEMATOPOIETIC PROGENITOR CELLS

EHA Library, Yongjian Yue, 4161183

THERAPY RELATED CLONAL HEMATOPOESIS IS ASSOCIATED WITH INCREASED EPIGENETIC AGE ACCELERATION, INCREASED PACE OF AGING AND SHORTED ESTIMATED TELOMERE LENGTHS

EHA Library, Marissa Li, 4161184

AUTOIMMUNE CYTOPENIAS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES

EHA Library, Irina Krobinets, 4161185

EXPANDED TRANSCRIPTION FACTOR NETWORK AND EARLY MEGAKARYOPOIESIS REGULATION BY THE GFI1B-KDM1A-HDAC COMPLEX IN THE IMMORTALIZED MEGAKARYOCYTE PROGENITOR CELL LINE IMMKCL

EHA Library, Eshani Ganjoo, 4161186

PARP INHIBITORS IMPAIR ERYTHROPOIESIS THROUGH P53 ACTIVATION

EHA Library, Charlotte Chambrion, 4161187

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-INDUCED ADIPOGENIC BIAS OF BONE MARROW MESENCHYMAL STROMAL CELLS: EVIDENCE OF SKEWED FATE AND VARIABLE REPROGRAMMING

EHA Library, Bexultan Kazybay, 4161188

MOSAIC CHROMOSOMAL ABERRATIONS AND ASSOCIATION TO HEMATOLOGICAL CANCER

EHA Library, Pei Meng, 4161189

SINGLE-CELL SEQUENCING REVEALED THE INFLAMMATORY SEGREGATION PHENOMENON AND THE KEY ROLE OF CLASSICAL DENDRITIC CELLS IN PEDIATRIC UNICENTRIC CASTLEMAN DISEASE

EHA Library, Shiwen Hu, 4161190

DISRUPTED GLUTAMINE METABOLISM ALTERS MACROPHAGE FUNCTION IN THE BONE MARROW.

EHA Library, Maddie Bristow, 4161191

LEUKEMIA EXOSOMES INDUCE IMMUNE SUPPRESSION IN DENDRITIC CELLS THROUGH ANTIGEN PRESENTATION AND IMMUNE METABOLISM REGULATION

EHA Library, Jinglong Lv, 4161192

INNOVATIVE SDAB-BASED CAR-T CELLS TARGETING BCMA OUTPERFORM CURRENT CAR-T THERAPIES FOR MULTIPLE MYELOMA

EHA Library, Juan Rodriguez-Madoz, 4161193

TARGETED LIPID NANOPARTICLE DELIVERY ENABLES IN VIVO HBG1/2 GENOME EDITING IN NON-HUMAN PRIMATES

EHA Library, Anshul Gupta, 4161194

TREATMENT WITH IMMUNOCHEMOTHERAPY DECREASES THE FITNESS OF CD19 CAR T-CELLS IN DLBCL

EHA Library, Tessa Knol, 4161195

ENHANCED LEUKEMIA IMMUNOTHERAPY WITH EXPANDED NKG2C+ NATURAL KILLER CELLS

EHA Library, Manja Wobus, 4161196

HIGHLY EFFICIENT AND SEAMLESS IN VIVO SELECTION OF LONG-RANGE GENE-EDITED HSPCS BY TARGETING HAPLOINSUFFICIENT GENES

EHA Library, Alessandra Weber, 4161197

INTEGRATED METABOLIC AND CYTOKINE PROFILING REVEALS IN VIVO METABOLIC CHECKPOINTS FOR CAR T-CELLS EFFICACY

EHA Library, Josquin Moraly, 4161198

ENGINEERING ROR1-SPECIFIC CAR T CELLS AGAINST LOW ANTIGEN DENSITY TUMORS

EHA Library, Federico Mario Aletti, 4161199

BEYOND EXPANSION: CIRCULATING TUMOR DNA AS A PROGNOSTIC BIOMARKER IN CAR T-CELL THERAPY FOR HIGH GRADE B-CELL LYMPHOMAS

EHA Library, Giada Zanirato, 4161200

CAR-T CELLS FROM PATIENTS WITH NON-HODGKIN LYMPHOMAS SECRETE FACTORS ABLE TO ACTIVATE THE MONOCYTIC-MACROPHAGIC TRANSITION: AN IN VITRO MODEL

EHA Library, Besjana Xhahysa, 4161201

TARGETING CATHEPSIN G PEPTIDES ON TWO DIFFERENT HLA MOLECULES WITH AN INDIVIDUAL T CELL RECEPTOR: A PROMISING APPROACH FOR ACUTE MYELOID LEUKEMIA IMMUNOTHERAPY

EHA Library, Eliana Ruggiero, 4161202

ERYTHROID SPECIFIC EPIGENETIC SUPPRESSION OF BCL11A OR ZNF410 EFFICIENTLY REACTIVATES GAMMA GLOBIN EXPRESSION IN NORMAL AND THALASSEMIC CD34+ CELLS

EHA Library, Kiriaki Paschoudi, 4161203

IN-DEPTH MOLECULAR AND CELLULAR CHARACTERIZATION OF A SENESCENT-LIKE, TERMINALLY DIFFERENTIATED CD8+ T CELL SUBSET IDENTIFIES A NOVEL METABOLIC TARGET FOR CANCER IMMUNOTHERAPY

EHA Library, Lea Philine Märker, 4161204

IMPROVING CAR-T CELL THERAPY FOR PDAC BY GENERATION OF VHH-BASED BINDERS

EHA Library, Alexander Seitz, 4161205

CMV SEROPOSITIVITY INFLUENCES T CELL RECONSTITUTION FOLLOWING CAR-T THERAPY

EHA Library, Jared Darcy, 4161206

ENGINEERING IPSC-DERIVED UNIVERSAL CAR-T CELLS WITH DUAL CD19/BCMA SPECIFICITY FOR AUTOIMMUNE DISEASE THERAPY

EHA Library, Yongqin Li, 4161207

ATRA INCREASES INKT CELL-MEDIATED TARGETING IN HEMATOLOGICAL MALIGNANCIES BY INDUCING CD1D EXPRESSION

EHA Library, Eliska Jandova, 4161208

FEATURES OF MONOCYTE IMMUNOPHENOTYPE IN LEUKOCONCENTRATES OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maria Morozova, 4161209

CAR-T CELL DYNAMICS AND MYELOID-CELL ALTERED PROFILE ARE ASSOCIATED WITH CLINICAL OUTCOME IN ANTI-CD19 CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL MALIGNANCIES: A REAL-LIFE COHORT STUDY

EHA Library, Maddalena Noviello, 4161210

EVALUATION OF MESENCHYMAL STEM CELL INTERMEDIATES IN 2015-2023

EHA Library, Hana Gmucova, 4161211

GREATWALL INHIBITOR-POTENTIAL NOVEL TREATMENT IN HEMATOLOGICAL MALIGNANCIES?

EHA Library, Elaina Pasangha, 4161212

INKT-BASED CELLULAR PRODUCT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE

EHA Library, Monika Holubova, 4161213

MAXIMIZING SAFETY AND EFFICACY IN HEMATOPOIETIC STEM CELLS GENE THERAPY

EHA Library, Valeriya Olevska, 4161214

ENHANCING CAR-T CELL HOMING TO AML BONE MARROW VIA CHEMOKINE RECEPTOR ENGINEERING

EHA Library, Alice Pievani, 4161215

EXPERIENCE OF USING A MICRONUCLEUS TEST TO CONTROL GENETIC INSTABILITY OF CAR-T LYMPHOCYTES AFTER TRANSDUCTION WITH LENTIVIRUS PARTICLES

EHA Library, Svetlana Popova, 4161216